Why the study?
Patients with systemic sclerosis experience endothelial dysfunction and damage even without clinical manifestations, prompting evaluation of methods to assess endothelial function in clinical practice.
Do patients with systemic sclerosis exhibit worse endothelial function compared to matched controls?
Comparison
Patients with systemic sclerosis vs matched controls
Design
Case-control study
Authors
Loading...
Ultrasonography detects endothelial dysfunction in systemic sclerosis; leaves open its clinical utility or prognostic value.
Do patients with systemic sclerosis exhibit worse endothelial function compared to matched controls?
Patients with systemic sclerosis exhibit significant endothelial dysfunction, detectable via ultrasonographic methods like FMD and IMT, compared to matched controls.
Pacholczak‐Madej et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: